SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
VTRS

Viatris Inc (NASDAQ:VTRS)

US · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
18.25+0.25 (+1.40%)
 
Market cap
$21.0B
Analyst consensus
Listed since
Mar 17, 1980
Insider Score
––Not scored
VTRS Insider Score

Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

VTRS Income Statement

Fiscal PeriodQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
Revenue3.76 B3.52 B3.70 B3.76 B3.58 B3.25 B
Revenue Growth (YoY)4.88 %8.07 %4.97 %0.23 %-5.65 %-11.17 %
Cost of Revenue2.30 B2.36 B2.57 B2.38 B2.25 B2.09 B
Gross Profit1.46 B1.16 B1.13 B1.38 B1.33 B1.16 B
SG&A Expense1.13 B928.80 M1.03 B882.90 M928.70 M948.10 M
R&D Expense248.30 M248.60 M274.70 M250.40 M218.80 M222.00 M
Operating Expenses1.45 B1.24 B1.40 B1.13 B1.10 B4.04 B
Operating Income6.30 M-79.70 M-265.50 M251.60 M233.00 M-2.88 B
Pretax Income-64.00 M-247.30 M-343.00 M-7.90 M-217.10 M-3.10 B
Tax Provision54.80 M-423.70 M-2.90 M120.30 M-212.50 M-55.00 M
Net Income-118.80 M176.40 M-340.10 M-128.20 M-4.60 M-3.04 B
EPS (Basic)-0.100.15-0.30-0.11-0.00-2.55
EPS (Diluted)-0.100.15-0.30-0.11-0.00-2.55
Shares Outstanding1.16 B1.16 B1.15 B1.16 B1.17 B1.19 B

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.